Old Mission Capital LLC Amgen Inc Transaction History

Old Mission Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $2.84 Million - $3.25 Million	-14,293 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $3.03 Million - $3.55 Million	14,293 New	14,293 $3.04 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $208,595 - $243,084	-940 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $220,571 - $245,293	940 New	940 $239,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $592,440 - $727,006	-2,995 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $545,808 - $723,891	2,995 New	2,995 $607,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $574,028 - $670,824	-3,388 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $571,860 - $638,942	3,388 New	3,388 $589,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $577,150 - $658,950	-3,450 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	3,450	3,450 $594,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.